Before you leave...
Take 20% off your first order
20% off
Enter the code below at checkout to get 20% off your first order
Handbook of Lymphoma (Paperback) (ISBN-13: 9783319084664)
Vendor:
Anas Younes
Product type:
Books
- $54.99
$54.99- $54.99
- Unit price
- per
Subtotal:
$54.99
Description
xThe Handbook of Lymphoma is an in-depth and comprehensive guide to the diagnosis, staging, treatment, and management of patients with the disease. The Handbook aims to provide healthcare professionals with an informative and up-to-date guide to the latest developments in the treatment of patients with both Hodgkin and non-Hodgkin lymphoma. Lymphoma is a cancer of the lymphatic system and, as with other cancers, is a disease of the body's cells. Usually, cells divide in the body in an orderly and controlled manner, however when this process gets out of control and the cells carry on dividing in an abnormal manner a tumor can form known as lymphoma in one or more groups of lymph nodes. This field has seen increasing development in the available options for treating patients with lymphoma particularly in the recent emergence and approval of targeted therapies. In this clinically focused Handbook, the authors address these advances by looking at treatment recommendations for both Hodgkin and non-Hodgkin lymphoma, and also making suggestions on the future outlook for patients with this disease. This Handbook is an invaluable and educational source of topical information for all medical and healthcare professionals with an interest in lymphoma.
Author: Anas Younes
ISBN-10: 3319084666
ISBN-13: 9783319084664
Publisher: Adis
Language: English
Published: 09/28/2016
Pages: 112
Format: Paperback
Weight: 0.30lbs
Size: 8.00h x 5.00w x 0.28d
Author: Anas Younes
ISBN-10: 3319084666
ISBN-13: 9783319084664
Publisher: Adis
Language: English
Published: 09/28/2016
Pages: 112
Format: Paperback
Weight: 0.30lbs
Size: 8.00h x 5.00w x 0.28d
By Anas Younes
xAnas Younes, MD, is the Chief of the Lymphoma Service at Memorial Sloan Kettering Cancer Center and Professor of
Medicine at Weill-Cornell Medical College, New York, NY, USA. He has extensive experience in clinical and translational research in lymphoma. He was the Principal Investigator of the MD Anderson Cancer Center Lymphoma
SPORE grant, and is currently the Principal Investigator of the Memorial Sloan Kettering Cancer Center Lymphoma SPORE grant. He has lead more than 60 clinical trials in lymphoma. He has lead, in collaboration with colleagues from around the world, the pivotal trials that resulted in the US FDA approval of brentuximab vedotin and nivolumab for the treatment of patients with relapsed Hodgkin lymphoma. He has published more than 250 papers on lymphoma.
Medicine at Weill-Cornell Medical College, New York, NY, USA. He has extensive experience in clinical and translational research in lymphoma. He was the Principal Investigator of the MD Anderson Cancer Center Lymphoma
SPORE grant, and is currently the Principal Investigator of the Memorial Sloan Kettering Cancer Center Lymphoma SPORE grant. He has lead more than 60 clinical trials in lymphoma. He has lead, in collaboration with colleagues from around the world, the pivotal trials that resulted in the US FDA approval of brentuximab vedotin and nivolumab for the treatment of patients with relapsed Hodgkin lymphoma. He has published more than 250 papers on lymphoma.
Recently Viewed Products
- Choosing a selection results in a full page refresh.